CLK2 and colorectal carcinoma: Additionally, CLK1, a novel CLK kinases inhibitor, has been reported to impair the growth of CRC cell lines and organoids, and inhibit anchorage-independent colony formation and cell migration, thus promoting cytotoxicity (Sohail et al., 2021).